NetworkNewsBreaks — Viveve Medical Inc. (NASDAQ: VIVE) Releases Q3 2022 Financial Report, Corporate Update
Viveve Medical (NASDAQ: VIVE), a medical technology company focused on women's health and the treatment of female stress urinary incontinence (“SUI”), has reported its financial results for the third quarter 2022, the period ended Sept. 30, 2022. Highlights of the report include total revenue for the company reaching $1.7 million for the third quarter 2022, increasing the installed base of Viveve Systems to 915 worldwide, with 479 in the United States and 436 internationally; approximately 3,100 single-use disposable treatment tips sold globally; advanced 12-month follow-up visits in pivotal U.S. PURSUIT clinical trial for SUI targeting completion of final follow visits…